Mesothelioma.com Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Cesar A. Moran, MD

Dr. Moran
Houston, TX

Dr. Cesar A. Moran

Co-Director, Thoracic Malignancies Tissue Bank & Co-Director, (Pathology) Lung Cancer SPORE

The University of Texas MD Anderson Cancer Center

1515 Holcombe Boulevard
Houston, TX 77030
713.792.8134

Need Help Contacting This Doctor?

Dr. Cesar Moran is a recognized specialist and researcher for mesothelioma. He currently is an associate director and adjunct professor at the University of Texas MD Anderson Cancer Center. Dr. Moran has served as the Principal Investigator for a number of funded research projects concerning cancer-related pathology. Aside from his academic obligations, Dr. Moran is the Editor-In-Chief of the Annals of Diagnostic Pathology while also serving on the editorial board or working as a reviewer for eight other medical journals.

Dr. Moran has authored and co-authored a number of scholarly writings including "VM104 Tumors of the Pleural and Mediastinum," which he co-authored with Saul Suster for the College of American Pathologists. The paper includes an in-depth analysis of pleural malignant mesothelioma, a fatal form of cancer that is typically caused by exposure to asbestos. Dr. Moran works to train pathologists in specific areas of cancer pathology, such as mesothelioma, and examines procedures such as extrapleural pneumonectomy as a method of treatment for mesothelioma cancer.

Main Specialty: Pathology

Other Interests & Specialties: Anatomic pathology, mesothelioma, lung cancer, skin cancer, tissue biopsy, vascular cancer, lymphatic diseases, smooth muscle cancer, breast cancer, liver cancer and mediastinal cyst.

Certifications, Awards & Accolades: American Board of Pathology Certified Anatomic Pathology, Top Doctors in America, SE Texas Top Doctors, Distinguished Teaching Professor, Super Doc Award, member of CCSG-NCI Lung Cancer Program, Leonard H. Robinson Award for Excellence in Education

Education & Experience:

Publications:
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma. Annals of Diagnostic Pathology. June 2014;18(3):140-5. doi: 10.1016/j.anndiagpath.2014.02.005

Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases. Histopathology. May 2008;52(7):824-830. doi: 10.1111/j.1365-2559.2008.03029.x

Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. American Journal of Clinical Pathology. November 2008;130(5):754-64. doi: 10.1309/AJCPHV33LJTVDGJJ

Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Advances in Anatomic Pathology. November 2006;13(6):316-29. doi: 10.1097/01.pap.0000213064.05005.64

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Share
Tweet
Share
Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide